Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.260
-0.040 (-3.08%)
At close: May 8, 2026, 4:00 PM EDT
1.290
+0.030 (2.38%)
After-hours: May 8, 2026, 5:17 PM EDT
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $5.07 million as of May 8, 2026. Its market cap has increased by 12.01% in one year.
Market Cap
5.07M
Enterprise Value
-2.45M
1-Year Change
12.01%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $5.07M, a decrease of -91.18%. That is a compound annual growth rate of -40.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 5.07M | -17.88% |
| Dec 31, 2025 | 6.17M | 124.01% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | 57.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CollPlant Biotechnologies | 5.80M |
| Enveric Biosciences | 5.66M |
| MetaVia | 5.63M |
| Clearmind Medicine | 5.61M |
| Cardio Diagnostics Holdings | 5.42M |
| Mustang Bio | 5.27M |
| BioRestorative Therapies | 5.24M |
| BiomX | 4.92M |